EA004800B1 - Способ лечения диабета росиглитазоном и инсулином - Google Patents

Способ лечения диабета росиглитазоном и инсулином Download PDF

Info

Publication number
EA004800B1
EA004800B1 EA200000042A EA200000042A EA004800B1 EA 004800 B1 EA004800 B1 EA 004800B1 EA 200000042 A EA200000042 A EA 200000042A EA 200000042 A EA200000042 A EA 200000042A EA 004800 B1 EA004800 B1 EA 004800B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
pharmaceutically acceptable
diabetes
acceptable form
insulin
Prior art date
Application number
EA200000042A
Other languages
English (en)
Russian (ru)
Other versions
EA200000042A1 (ru
Inventor
Стефен Элистэр Смит
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000042A1 publication Critical patent/EA200000042A1/ru
Publication of EA004800B1 publication Critical patent/EA004800B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200000042A 1997-06-18 1998-06-15 Способ лечения диабета росиглитазоном и инсулином EA004800B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
PCT/EP1998/003692 WO1998057636A1 (fr) 1997-06-18 1998-06-15 Nouvelle methode de traitement

Publications (2)

Publication Number Publication Date
EA200000042A1 EA200000042A1 (ru) 2000-08-28
EA004800B1 true EA004800B1 (ru) 2004-08-26

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000042A EA004800B1 (ru) 1997-06-18 1998-06-15 Способ лечения диабета росиглитазоном и инсулином

Country Status (30)

Country Link
EP (1) EP0999837A1 (fr)
JP (1) JP2002504138A (fr)
KR (1) KR20010013843A (fr)
CN (1) CN1133431C (fr)
AP (1) AP1287A (fr)
AR (2) AR015894A1 (fr)
AU (1) AU8216398A (fr)
BG (1) BG104059A (fr)
BR (1) BR9810444A (fr)
CA (1) CA2294141A1 (fr)
CO (1) CO4940454A1 (fr)
DZ (1) DZ2521A1 (fr)
EA (1) EA004800B1 (fr)
GB (1) GB9712866D0 (fr)
HU (1) HUP0003260A3 (fr)
ID (1) ID23951A (fr)
IL (1) IL133143A0 (fr)
IN (1) IN189723B (fr)
MA (1) MA26511A1 (fr)
NO (1) NO996265L (fr)
OA (1) OA11517A (fr)
PE (1) PE104499A1 (fr)
PL (1) PL343123A1 (fr)
SK (1) SK179399A3 (fr)
TR (1) TR199903095T2 (fr)
TW (1) TW587937B (fr)
UA (1) UA70299C2 (fr)
UY (1) UY25050A1 (fr)
WO (1) WO1998057636A1 (fr)
ZA (1) ZA985237B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
EP1133312B8 (fr) * 1999-06-21 2007-10-17 Eli Lilly And Company Utilisation combinee de thiazolidinediones et de peptide-1 de type glucagone et d'agonistes de ces derniers pour traiter diabetes non insulino-dependant.
WO2001000223A2 (fr) * 1999-06-25 2001-01-04 Minimed Inc. Therapie anti diabete a agents multiples
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
WO2002100396A1 (fr) * 2001-06-07 2002-12-19 Wyeth Combinaison d'un inhibiteur de la ptpase et d'un agent thiazolidinedione
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
AU2003276234B2 (en) 2002-11-08 2007-04-19 F. Hoffmann-La Roche Ag Substituted 4-alkoxyoxazol derivatives as PPAR agonists
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007694A1 (fr) * 1993-09-15 1995-03-23 Sankyo Company, Limited Utilisation de thiazolidinediones pour prevenir ou retarder l'apparition du diabete sucre non insulinodependant
WO1997005875A2 (fr) * 1995-08-10 1997-02-20 Warner-Lambert Company Procede permettant de reduire la quantite d'insuline exogene administree a un patient souffrant de diabete sucre non-insulinodependant
AU725998B2 (en) * 1995-09-18 2000-10-26 Eisai R&D Management Co., Ltd. Treating NIDDM with RXR agonists

Also Published As

Publication number Publication date
AU8216398A (en) 1999-01-04
NO996265D0 (no) 1999-12-17
WO1998057636A1 (fr) 1998-12-23
AR012997A1 (es) 2000-11-22
KR20010013843A (ko) 2001-02-26
IL133143A0 (en) 2001-03-19
CN1133431C (zh) 2004-01-07
TW587937B (en) 2004-05-21
SK179399A3 (en) 2000-11-07
EP0999837A1 (fr) 2000-05-17
JP2002504138A (ja) 2002-02-05
AR015894A1 (es) 2001-05-30
CN1260715A (zh) 2000-07-19
OA11517A (en) 2004-02-04
IN189723B (fr) 2003-04-19
AP9901718A0 (en) 1999-12-31
UY25050A1 (es) 2000-09-29
DZ2521A1 (fr) 2003-02-08
ZA985237B (en) 2000-02-17
MA26511A1 (fr) 2004-12-20
TR199903095T2 (xx) 2000-08-21
NO996265L (no) 1999-12-17
AP1287A (en) 2004-06-26
BG104059A (en) 2000-10-31
HUP0003260A2 (hu) 2001-05-28
ID23951A (id) 2000-06-08
PL343123A1 (en) 2001-07-30
CA2294141A1 (fr) 1998-12-23
EA200000042A1 (ru) 2000-08-28
BR9810444A (pt) 2000-09-05
HUP0003260A3 (en) 2001-12-28
UA70299C2 (en) 2004-10-15
CO4940454A1 (es) 2000-07-24
PE104499A1 (es) 2000-01-13
GB9712866D0 (en) 1997-08-20

Similar Documents

Publication Publication Date Title
KR100666591B1 (ko) 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
EA004800B1 (ru) Способ лечения диабета росиглитазоном и инсулином
SK285484B6 (sk) Kombinácia obsahujúca 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, inzulínový sekrečný promótor a biguanidovú antihyperglykémickú látku, farmaceutický prostriedok s jej obsahom a ich použitie na liečbu diabetu
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
EP0999845B1 (fr) Traitement du diabete a l'aide de thiazolidinedione et de sulfonyluree
SK179499A3 (en) The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
US20020028768A1 (en) Treatment of diabetes with rosiglitazone and insulin
MXPA99012065A (en) Treatment of diabetes with rosiglitazone and insulin
NZ518076A (en) 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (BRL49653) for treating non-insulin dependent diabetes (NIDDM)
UA68352C2 (en) Method for treatment of diabetes mellitus with thiazolidin and metformin
MXPA99012098A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
CZ9904579A3 (cs) Léčivo pro léčbu diabetes mellitus a stavů spojených s diabetes mellitus

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU